1. Japan Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Waqoo Inc.

Waqoo Inc.

TTSE:4937
2,347.00
JPY
+25.00
(+1.08%)
4.86BMarket Cap
Nov 12Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,157.7
1,664.57
1,678.03
909.89
574.95
561.08
547.96
- -
Basic EPS, GAAP
-271.65
36.45
41.61
-19.04
9.45
-5.03
12.32
- -
Free Cash Flow per Basic Share
-343.95
32.23
-49.48
56.15
151.82
-8.98
-15.88
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
21.43
55.16
266.74
247
256.75
591.42
593.77
633.21
Tangible Book Value per Share
14.84
49.74
260.12
242.4
254.11
277.52
306.57
365.1
Basic Weighted Avg Shares
3
3
3
3
3
3
4
4
Sales/Revenue/Turnover
3,386
4,505
4,682
2,731
1,726
1,943
1,961
- -
Operating Margin (%)
-23.29
2.38
3.19
-1.46
16.1
2.89
7.7
- -
Depreciation Expense
2
5
6
6
6
105
136
- -
Net Income, GAAP
-795
99
116
-57
28
-17
44
- -
Effective Tax Rate (%)
- -
9.18
17.4
- -
17.08
130.37
71.07
- -
Profit Margin (%)
-23.47
2.19
2.48
-2.09
1.64
-0.9
2.25
- -
Working Capital
321
386
1,163
789
1,058
1,257
1,090
1,231
LT Debt
287
252
389
266
305
395
341
267
Total Equity
63
161
801
743
773
2,140
2,092
2,243
Return on Invested Capital (%)
- -
13.03
10.03
- -
16.27
-0.78
1.49
- -
Return on Capital (%)
- -
14.4
10.29
- -
2.21
-0.87
1.62
- -
Return on Common Equity (%)
- -
88.06
24.14
-7.41
3.74
-1.19
2.08
- -

Capital Structure

JPY

•

in mil. unless spec.
Mar'24
Dec'26
Mar'26
ST Debt
374
- -
361
LT Borrowings
428
- -
267
LT Finance Leases
1
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
6,608
4,865
4,861

Working Capital

JPY

•

in mil. unless spec.
Mar'24
Dec'26
Mar'26
Total Current Assets
1,821
- -
2,043
Cash, Cash Equivalents & STI
1,495
- -
1,369
Accounts Receivable, Net
155
- -
522
Inventories
146
- -
108
Total Current Liabilities
611
- -
812
Payables & Accruals
- -
- -
- -
ST Debt
374
- -
361
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
113.54%
-2.27%
Free Cash Flow
- -
-66.82%
82.64%
Net Income, GAAP
- -
-159.16%
-353.32%
Sales/Revenue/Turnover
- -
-12.21%
0.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
446
488
- -
- -
1,943
2025
- -
- -
- -
- -
1,961
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-36.67
-0.16
- -
- -
-5.03
2025
- -
- -
- -
- -
12.32
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Hiroki Inoue
Full Time Employees
93
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Yokomizo Building Tokyo TY Japan 154-0011
IPO Date
Jun 29, 2021
Website
waqoo.jp
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Waqoo Inc. (4937.T) engages primarily in the direct-to-consumer (D2C) business, planning, developing and selling cosmetics through its e-commerce platform; it also provides medical support services in regenerative medicine. The company offers skin care products including premium moist gel, cleansing oil, facial cleanser, hot cleansing balm, whitening serum, whitening face wash, serum and whitening cleansing under the HADA NATURE brand; makeup base; proteins; and hair care products such as botanical shampoo, hair oil and mask, and head spa hair growth agent. Incorporated in 2005 and headquartered in Setagaya-ku, Tokyo, Japan, Waqoo operates principally in Japan with 86 employees and focuses on beauty and health sectors targeting general consumers via digital marketing. In the medical support segment, it delivers advertising services and regenerative medicine contract processing including blood-derived and fat-derived stem cell services; its D2C revenue constitutes the majority alongside growing medical contributions. In November 2025, SBC Medical Group Holdings Inc. (SBC), through its Japanese subsidiary, commenced a tender offer for up to 575,000 shares of Waqoo at JPY 1,900 per share from November 14 to December 12, with settlement on December 19, aiming to consolidate Waqoo as a subsidiary following SBC's existing 9.49% stake and related-party share transfers to enhance R&D in AGA, orthopedics, skincare and global regenerative medicine. Waqoo completed an equity buyback of 100,000 shares (2.78% of outstanding) in March 2025 for JPY 99.92 million.